메뉴 건너뛰기




Volumn 18, Issue 3, 2012, Pages 193-200

Primary hyperaldosteronism among Chinese hypertensive patients: How are we doing in a local district in Hong Kong

Author keywords

Adrenal cortex neoplasms; Aldosterone; Hyperaldosteronism; Hypertension; Prevalence

Indexed keywords

ALDOSTERONE; AMILORIDE; ANTIHYPERTENSIVE AGENT; RENIN; SPIRONOLACTONE;

EID: 84862533364     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (23)
  • 1
    • 84876481499 scopus 로고    scopus 로고
    • Collaborative Project of Department of Health and Department of Community Medicine, University of Hong Kong. Population Health survey 2003/2004. Centre for Health Protection website, Accessed Dec 2011
    • Collaborative Project of Department of Health and Department of Community Medicine, University of Hong Kong. Population Health survey 2003/2004. Centre for Health Protection website: http://www.chp.gov.hk/files/pdf/full_report_on_population_health_survey_2003_2004_en_20051024.pdf. Accessed Dec 2011.
  • 2
    • 84876474542 scopus 로고    scopus 로고
    • Hong Kong Morbidity Survey 2007-2008
    • Lo CY, Lam LK, Lam TP, et al. Hong Kong Morbidity Survey 2007-2008. Hong Kong Pract 2010;32:18-26.
    • (2010) Hong Kong Pract , vol.32 , pp. 18-26
    • Lo, C.Y.1    Lam, L.K.2    Lam, T.P.3
  • 3
    • 84876489046 scopus 로고    scopus 로고
    • Legislative Council Panel on Health Services Information Note on Services of Public Out-patient Clinics; LC Paper No. CB(2)729/10-11(07). Legco website, Accessed Dec 2011
    • Legislative Council Panel on Health Services Information Note on Services of Public Out-patient Clinics; LC Paper No. CB(2)729/10-11(07). Legco website: http://www.legco.gov.hk/yr10-11/english/panels/hs/papers/hs0110cb2-729-7-e.pdf. Accessed Dec 2011.
  • 4
    • 0029932583 scopus 로고    scopus 로고
    • Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong
    • Lau GS, Chan JC, Chu PL, Tse DC, Critchley JA. Use of antidiabetic and antihypertensive drugs in hospital and outpatient settings in Hong Kong. Ann Pharmacother 1996;30:232-7.
    • (1996) Ann Pharmacother , vol.30 , pp. 232-237
    • Lau, G.S.1    Chan, J.C.2    Chu, P.L.3    Tse, D.C.4    Critchley, J.A.5
  • 5
    • 84876502556 scopus 로고    scopus 로고
    • Sham Shui Po Healthy and Safety website, Accessed Dec 2011
    • Sham Shui Po Healthy and Safety website: http://www.safecommunity.hk/ssp/e_setting2.html. Accessed Dec 2011.
  • 6
    • 0037286980 scopus 로고    scopus 로고
    • Diagnosing secondary hypertension
    • Onusko E. Diagnosing secondary hypertension. Am Fam Physician 2003;67:67-74.
    • (2003) Am Fam Physician , vol.67 , pp. 67-74
    • Onusko, E.1
  • 7
    • 84861641809 scopus 로고    scopus 로고
    • Endocrine hypertension-strategy for screening and workup
    • Chan WB. Endocrine hypertension-strategy for screening and workup. Hong Kong Med Diary 2006;11:12-5.
    • (2006) Hong Kong Med Diary , vol.11 , pp. 12-15
    • Chan, W.B.1
  • 8
    • 17144421237 scopus 로고    scopus 로고
    • Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
    • Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-8.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1243-1248
    • Milliez, P.1    Girerd, X.2    Plouin, P.F.3    Blacher, J.4    Safar, M.E.5    Mourad, J.J.6
  • 9
    • 77956642514 scopus 로고    scopus 로고
    • Target organ damage in hyperaldosteronism versus essential hypertension-the Beer Sheba experience [in Hebrew]
    • Wolak T, Hazkani I, Friger M, Paran E. Target organ damage in hyperaldosteronism versus essential hypertension-the Beer Sheba experience [in Hebrew]. Harefuah 2010;149:161- 5,194.
    • (2010) Harefuah , vol.149
    • Wolak, T.1    Hazkani, I.2    Friger, M.3    Paran, E.4
  • 10
    • 0032542244 scopus 로고    scopus 로고
    • Primary aldosteronism
    • Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-34.
    • (1998) N Engl J Med , vol.339 , pp. 1828-1834
    • Ganguly, A.1
  • 11
    • 1642390149 scopus 로고    scopus 로고
    • Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents
    • Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 2004;89:1045-50.
    • (2004) J Clin Endocrinol Metab , vol.89 , pp. 1045-1050
    • Mulatero, P.1    Stowasser, M.2    Loh, K.C.3
  • 12
    • 0033513989 scopus 로고    scopus 로고
    • Potentially high prevalence of primary aldosteronism in a primary-care population
    • Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM. Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 1999;353:40.
    • (1999) Lancet , vol.353 , pp. 40
    • Lim, P.O.1    Rodgers, P.2    Cardale, K.3    Watson, A.D.4    Macdonald, T.M.5
  • 13
    • 33748132658 scopus 로고    scopus 로고
    • A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
    • Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293-300.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2293-2300
    • Rossi, G.P.1    Bernini, G.2    Caliumi, C.3
  • 14
    • 0037799888 scopus 로고    scopus 로고
    • Minireview: Primary aldosteronism-changing concepts in diagnosis and treatment
    • Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003;144:2208-13.
    • (2003) Endocrinology , vol.144 , pp. 2208-2213
    • Young Jr., W.F.1
  • 15
    • 0037500115 scopus 로고    scopus 로고
    • Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region
    • Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J Jr. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003;17:349-52.
    • (2003) J Hum Hypertens , vol.17 , pp. 349-352
    • Strauch, B.1    Zelinka, T.2    Hampf, M.3    Bernhardt, R.4    Widimsky Jr., J.5
  • 16
    • 0042266234 scopus 로고    scopus 로고
    • Primary aldosteronism and hypertensive disease
    • Mosso L, Carvajal C, González A, et al. Primary aldosteronism and hypertensive disease. Hypertension 2003;42:161-5.
    • (2003) Hypertension , vol.42 , pp. 161-165
    • Mosso, L.1    Carvajal, C.2    González, A.3
  • 17
    • 34548688396 scopus 로고    scopus 로고
    • Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patient with medication?
    • Nishikawa T, Saito J, Omura M. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patient with medication? Endocr J 2007;54:487-95.
    • (2007) Endocr J , vol.54 , pp. 487-495
    • Nishikawa, T.1    Saito, J.2    Omura, M.3
  • 19
    • 51749083776 scopus 로고    scopus 로고
    • Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline
    • Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008;93:3266-81.
    • (2008) J Clin Endocrinol Metab , vol.93 , pp. 3266-3281
    • Funder, J.W.1    Carey, R.M.2    Fardella, C.3
  • 20
    • 12244255086 scopus 로고    scopus 로고
    • The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling
    • Tiu SC, Choi CH, Shek CC, et al. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005;90:72-8.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 72-78
    • Tiu, S.C.1    Choi, C.H.2    Shek, C.C.3
  • 21
    • 9444291913 scopus 로고    scopus 로고
    • Primary aldosteronism. Results of surgical treatment
    • Lo CY, Tam PC, Kung AW, Lam KS, Wong J. Primary aldosteronism. Results of surgical treatment. Ann Surg 1996;224:125-30.
    • (1996) Ann Surg , vol.224 , pp. 125-130
    • Lo, C.Y.1    Tam, P.C.2    Kung, A.W.3    Lam, K.S.4    Wong, J.5
  • 22
    • 0036443145 scopus 로고    scopus 로고
    • Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism
    • Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002;89:1587-93.
    • (2002) Br J Surg , vol.89 , pp. 1587-1593
    • Sywak, M.1    Pasieka, J.L.2
  • 23
    • 84876476591 scopus 로고    scopus 로고
    • Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004. National Heart Lung and Blood Institute website, Accessed Dec 2011
    • Bethesda MD. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. 2004. National Heart Lung and Blood Institute website: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Accessed Dec 2011.
    • (2003)
    • Bethesda, M.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.